Trial Profile
An 8-Week, Prospective, Multicenter, Open-Label Study of OTO-201 Given as a Single Administration in Pediatric Subjects With a History of Otitis Media Requiring Tympanostomy Tubes
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Oct 2020
Price :
$35
*
At a glance
- Drugs Ciprofloxacin (Primary)
- Indications Otitis media
- Focus Therapeutic Use
- Sponsors Otonomy [CEASED]
- 03 Aug 2017 According to an Otonomy media release, results from this study were presented at the American Society of Pediatric Otolaryngology (ASPO) Annual Meeting 2017.
- 12 May 2017 According to an Otonomy media release, data will be presented at the American Society of Pediatric Otolaryngology (ASPO) Annual Meeting 2017.
- 15 Sep 2016 According to an Otonomy media release, full results from the trial will be presented at an upcoming medical conference.